MedTrace Logo

Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections

NCT01066507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2010-02-10

No results posted yet for this study

Summary

The purpose of the study is the identification of amplification level in human breast tissue. The imaging system is intended for diagnostic use as an aid to the pathologist in the detection, counting and classification of Her2 FISH stained tissue samples.

Conditions

Sponsors & Collaborators

  • Applied Spectral Imaging Ltd.

    lead INDUSTRY

Principal Investigators

  • Sheila Dobin, Ph.D. · Section Chief, Cytogenetics

Eligibility

Min Age
21 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States
  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01066507 on ClinicalTrials.gov